Skip to main content
Top
Published in: Acta Diabetologica 4/2011

01-12-2011 | Original Article

Long-term predictive power of simple function tests for cardiovascular autonomic neuropathy in diabetes: a population-based study

Authors: Ole May, Hanne Arildsen

Published in: Acta Diabetologica | Issue 4/2011

Login to get access

Abstract

No consensus exists on which test is optimal in screening for cardiovascular autonomic neuropathy in diabetic patients. The long-term predictive power of five simple function tests with regard to all-cause mortality in individuals with diabetes from the general population was assessed. The diabetic population in the municipality of Horsens, Denmark, was delineated by the prescription method, and an age- and gender-stratified sample of 240 diabetic persons was randomly selected. Five function tests were conducted: Valsalva ratio, heart rate response to standing (30:15 ratio), expiration/inspiration ratio (E/I ratio), ortostatic blood pressure response (Orto BP) and increase in diastolic blood pressure during sustained handgrip. After a 15½-year follow-up period, vital statistics were obtained from the Danish Civil Registration System. One hundred and seventy eight persons participated, 44% women, 40% type 1 diabetes, mean age 58.9 (SD 10.2) years. In Cox regression analysis, adjusting for age and gender, each test had a significant predictive effect on mortality (all P < 0.05). In the multivariate analysis, only Valsalva ratio (P = 0.0017), 30:15 ratio (P = 0.037) and handgrip (P = 0.037) were predictors of survival. As a binary variable, the presence of CAN was associated with a relative risk of all-cause death of 2.85 (95%CI: 1.75–4.65, P = 0.00003). In the period following the first 5 years, CAN’s predictive value remained significant. This study indicates that Valsalva, 30:15 ratio and handgrip, but not E/I ratio and Orto BP, have an independent predictive value with regard to long-term all-cause mortality. Baseline function tests hold prognostic information after at least 5 years.
Literature
1.
go back to reference Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579PubMedCrossRef Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579PubMedCrossRef
2.
go back to reference Ewing DJ, Campbell IW, Clarke BF (1980) The natural history of diabetic autonomic neuropathy. Q J Med 49:95–108PubMed Ewing DJ, Campbell IW, Clarke BF (1980) The natural history of diabetic autonomic neuropathy. Q J Med 49:95–108PubMed
3.
go back to reference Maser RE, Mitchell BD, Vinik AI, Freeman R (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care 26:1895–1901PubMedCrossRef Maser RE, Mitchell BD, Vinik AI, Freeman R (2003) The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care 26:1895–1901PubMedCrossRef
4.
go back to reference Neil HAW (1992) The epidemiology of diabetic autonomic neuropathy. In: Bannister R, Mathias CJ (eds) Autonomic failure. A textbook of clinical disorders of the autonomic nervous system, 3rd edn. Oxford University Press, Oxford, pp 682–697 Neil HAW (1992) The epidemiology of diabetic autonomic neuropathy. In: Bannister R, Mathias CJ (eds) Autonomic failure. A textbook of clinical disorders of the autonomic nervous system, 3rd edn. Oxford University Press, Oxford, pp 682–697
6.
go back to reference Gæde P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393PubMedCrossRef Gæde P, Vedel P, Larsen N, Jensen GVH, Parving H-H, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393PubMedCrossRef
7.
go back to reference DCCT-investigators (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef DCCT-investigators (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef
8.
go back to reference Kontopoulos AG, Athyros VG, Didangelos TP, Papageorgiou AA, Avramidis MJ, Mayroudi MC et al (1997) Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 20:355–361PubMedCrossRef Kontopoulos AG, Athyros VG, Didangelos TP, Papageorgiou AA, Avramidis MJ, Mayroudi MC et al (1997) Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 20:355–361PubMedCrossRef
9.
go back to reference Boulton AJM, Vinik AI, Arrezzo JC, Bril V, Feldman EL, Freeman R et al (2005) Diabetic neuropathies. Diabetes Care 28:956–962PubMedCrossRef Boulton AJM, Vinik AI, Arrezzo JC, Bril V, Feldman EL, Freeman R et al (2005) Diabetic neuropathies. Diabetes Care 28:956–962PubMedCrossRef
10.
go back to reference Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. B M J 285:916–918CrossRef Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. B M J 285:916–918CrossRef
11.
go back to reference ADA, AAN (1988) Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 11:592–597 ADA, AAN (1988) Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 11:592–597
12.
go back to reference (1992) Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Diab Care 15:1080–1107 (1992) Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Diab Care 15:1080–1107
13.
go back to reference May O, Arildsen H, Damsgaard EM, Mickley H (1997) Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study. Cardiovasc Res 34:241–247PubMedCrossRef May O, Arildsen H, Damsgaard EM, Mickley H (1997) Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study. Cardiovasc Res 34:241–247PubMedCrossRef
14.
go back to reference WHO Study Group (1985) Diabetes mellitus. World Health Organisation, Technical Report Series, Geneva, p 727 WHO Study Group (1985) Diabetes mellitus. World Health Organisation, Technical Report Series, Geneva, p 727
15.
go back to reference Damsgaard EM, Faber OK, Froland A, Green A, Hauge M, Holm N et al (1987) Prevalence of fasting hyperglycemia and known non-insulin-dependent diabetes mellitus classified by plasma C-peptide: Fredericia survey of subjects 60–74 year old. Diab Care 10:26–32CrossRef Damsgaard EM, Faber OK, Froland A, Green A, Hauge M, Holm N et al (1987) Prevalence of fasting hyperglycemia and known non-insulin-dependent diabetes mellitus classified by plasma C-peptide: Fredericia survey of subjects 60–74 year old. Diab Care 10:26–32CrossRef
16.
go back to reference Garrow JS (1963) Zero-muddler for unprejudiced sphygmomanometry. Lancet ii:1205 Garrow JS (1963) Zero-muddler for unprejudiced sphygmomanometry. Lancet ii:1205
17.
go back to reference Ziegler D (1999) Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev 7:300–315 Ziegler D (1999) Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev 7:300–315
18.
go back to reference Valensi P, Sachs R-N, Harfouche B, Lormeau B, Paries J, Cosson E et al (2001) Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diab Care 24:339–343CrossRef Valensi P, Sachs R-N, Harfouche B, Lormeau B, Paries J, Cosson E et al (2001) Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diab Care 24:339–343CrossRef
19.
go back to reference Orchard TJ, Lloyd CE, Maser RE, Kuller LH (1996) Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh epidemiology of diabetes Complications Study. Diab Res Clin Pract 34(suppl):S165–S171CrossRef Orchard TJ, Lloyd CE, Maser RE, Kuller LH (1996) Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh epidemiology of diabetes Complications Study. Diab Res Clin Pract 34(suppl):S165–S171CrossRef
Metadata
Title
Long-term predictive power of simple function tests for cardiovascular autonomic neuropathy in diabetes: a population-based study
Authors
Ole May
Hanne Arildsen
Publication date
01-12-2011
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2011
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-011-0283-z

Other articles of this Issue 4/2011

Acta Diabetologica 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.